Vera Therapeutics, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold256K-1.1M0563K0000
Gross Profit-256K1.1M0-563K0000
R&D Expenses86.0M59.6M56.5M58.1M41.3M33.3M40.3M29.3M
Operating Expenses125.1M95.3M83.9M79.6M57.2M48.9M49.8M37.3M
Operating Income-125.1M-94.2M-83.9M-80.1M-57.2M-48.9M-49.8M-37.3M
Other Income / Gains4.1M3.1M3.6M3.6M5.5M5.5M3.2M3.6M
Net Income-121.0M-91.1M-80.3M-76.5M-51.7M-43.4M-46.6M-33.7M
EPS (Diluted)-1.69-1.39-1.26-1.20-0.81-0.85-0.85-0.62
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses39.1M34.9M21.8M21.9M14.6M15.6M9.5M8.0M
Selling And Marketing Expenses005.7M01.3M000
Selling General And Administrative Expenses39.1M34.9M27.5M21.9M15.9M15.6M9.5M8.0M
Other Expenses0879K0-444K0000
Cost And Expenses125.1M94.2M83.9M80.1M57.2M48.9M49.8M37.3M
Interest Income6.4M19.0M5.7M6.3M6.9M6.7M4.8M5.1M
Interest Expense1.8M5.6M2.0M1.9M1.8M1.9M1.9M1.9M
Depreciation And Amortization256K135K129K563K85K55K24K1.5M
Ebitda-119.0M-85.3M-78.2M-74.1M-49.8M-41.5M-44.7M-30.3M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-121.0M-91.1M-80.3M-76.5M-51.7M-43.4M-46.6M-33.7M
Income Before Tax Ratio00000000
Income Tax Expense0-1K0001K00
Net Income Ratio00000000
Epsdiluted-1.69-1.39-1.26-1.20-0.81-0.85-0.85-0.62
Weighted Average Shs Out71.5M64.2M63.8M63.8M63.7M54.9M54.9M54.7M
Weighted Average Shs Out Dil71.5M64.2M63.8M63.8M63.7M54.9M54.9M54.7M